查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
集群规则间隔短回文重复技术到 2030 年的全球市场预测：按产品、应用、最终用户和地区进行分析
市场调查报告书
商品编码
1383406

集群规则间隔短回文重复技术到 2030 年的全球市场预测：按产品、应用、最终用户和地区进行分析

Clustered Regularly Interspaced Short Palindromic Repeats Technology Market Forecasts to 2030 - Global Analysis By Product, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 预测，2023 年全球 Clustered Regular Interspace Short Palindromic Repetition（Clustered Regular Interspace Short Palindromic Repetition）技术市场规模将达到 36 亿美元，预测期内年复合成长率为 17.6%。到2030 年将达到113 亿美元，预测期间内复合年增长率为 17.6%。到2030 年将达到113 亿美元，预测期内复合年增长率为 17.6%。到2030 年将达到113 亿美元，预测期内复合年增长率为 17.6%。到2030 年将达到113 亿美元。

成簇规则间隔短回文重复技术是商业性系统。成簇规则间隔短回文重复技术用于精确修改包括人类在内的多种生物体中的 DNA 序列，用于基因治疗、药物开发和农业进步等目的。簇状规则间隔短回文重复技术的优点是准确度高、经济实惠、效率高，使其成为基因编辑的革命性工具，在医学、生物技术和科学研究领域具有巨大潜力。

根据麦克马斯特大学2019年进行的一项研究，超过112万男性患有血友病，其中40万人患有严重血友病。

正在进行的临床试验不断增加

这些临床试验反映了人们对应用成簇规则间隔短回文重复技术来开发遗传性疾病、癌症和各种其他疾病的新治疗方法的兴趣和投资日益增长。随着临床试验的进展，使用集群定期间隔短回文重复的治疗方法的安全性和有效性检验，增加了法规、投资者和医疗保健提供者的信心。这不仅为可能的市场核准铺平了道路，而且扩大了簇状规则间隔短回文重复的应用范围，使其成为医学领域的变革力量。临床试验的数量表明该技术具有彻底改变医疗保健并支持未来市场成长的潜力。

聚集规则间隔短回文重复的高成本

集群规则空间短回文重复的应用所需的研究、设备和专业知识的初始投资可能令人望而却步。此外，严格的品管、严格的测试和法规遵循的需求也会增加整体成本。与簇状规则间隔短回文重复相关的智慧财产权的高额许可费用进一步加重了公司和研究机构的负担。这些高昂的成本限制了集群规则间隔短回文重复技术的获得，并抑制了创新和采用的步伐，特别是对于预算有限的小型研究机构和组织来说，这是有可能的。

增加政府和私人对集群规则间隔短回文重复技术的投资和资助

公共和私营部门增加的资金将促进集群规则间隔短回文重复应用的研究、开发和商业化。这种财政支持加速了创新，扩大了应用范围，并提高了技术的可近性。它还促进学术机构、生物技术公司和製药公司之间的合作，以在基因治疗、农业和药物研发等领域取得突破。此外，强有力的财政支持将促进法规合规性和道德考虑，并确保负责任和安全地使用集群规则间隔短回文重复技术。

集群规则间隔短回文重复发展的法规障碍

以伦理、安全和智慧财产权问题为特征的不断发展的法规环境可能会显着减缓群集规则间隔短回文重复应用的开发和商业化。各国严格的法规和不同的指导方针可能会给寻求销售基于集群规则间隔短回文重复的产品的研究人员和公司带来挑战。围绕人类基因编辑和农业潜在生态学影响的伦理争论使法规环境更加复杂。智慧财产权纠纷和许可复杂性也阻碍了创新和市场进入。这些障碍限制了集群定期间隔短回文重复技术的采用速度和范围，减缓了它们满足关键医疗需求、彻底改变农业和推进科学研究的潜力。

COVID-19 的影响：

COVID-19 大流行对集群常规间隔短回文重复技术市场产生了各种影响。虽然它暂时扰乱了供应链和实验室研究，但它也凸显了快速、准确的基因组编辑技术的重要性。簇状规则间隔短回文重复技术在诊断测试开发和疫苗研究中的潜力已得到证明。此外，疫情也加速了数位工具的采用以及远端存取与集群定期空间短回文重复相关的研究，使科学家更容易继续他们的工作。因此，簇状规则间隔短回文重复技术有可能吸引大流行之外的应用的关注和资金，并促进研究、医学和生物技术的成长和多样化。

簇状规则间隔短回文重复试剂盒和酵素部分预计在预测期内将是最大的

簇状规则间隔的短回文重复试剂盒和酶片段预计将有良好的增长。这些重要工具为研究人员提供了精确基因组编辑所需的组件。成簇规则间隔短回文重复试剂盒通常包括引导 RNA、Cas9 蛋白和靶向 DNA 修饰所需的其他试剂。 Cas9 等酵素负责在特定位点切割 DNA。这些酶的现成可用性简化了成簇规则间隔的短回文重复的工作流程，使它们在从基因治疗和药物研发到农业进步的广泛应用中更加高效和准确，操作成为可能。这些试剂盒和酶的便利性和可用性正在推动集群规则间隔短回文重复技术在各个科学和工业领域的广泛采用和持续增长。

预计农业部门在预测期内年复合成长率最高

预计农业部门在预测期内将呈现最快的年复合成长率。簇状规则间隔短回文重复技术为作物改良和牲畜育种提供准确、高效的基因组编辑工具，正在彻底改变农业产业。簇状规则间隔短回文重复技术能够开发出增强对害虫、疾病、不利环境条件的抵抗力并提高营养含量的基因改造作物。这项创新有可能提高作物产量、减少对化学农药的需求并应对粮食安全挑战。集群规则间隔短回文重复在农业中的应用为永续和更具弹性的粮食生产带来了巨大的希望，并且可以为人口增长和气候变迁面临的全球挑战提供重要的解决方案。这就是我们所提供的。

比最大的地区

预计北美市场在预测期内将继续占据大部分市场占有率。该地区拥有强大的集群规则间隔短回文重复研究和应用生态系统，其特点是主要生物技术公司、学术机构和研究中心高度集中。该地区先进的基础设施、对生命科学的大量投资以及支持性的法规环境促进了集群规则间隔短回文重复技术的快速创新。北美在临床试验、基因治疗进展以及基于成簇规则间隔短回文重复的治疗方法开发方面处于领先地位，使其成为生物技术突破的中心。强大的私人和公共资金以及熟练的人才库使北美成为推动集群常规间隔短回文重复市场成长和多样化的领导者。

复合年复合成长率最高的地区：

预计亚太地区在预测期内的年复合成长率最高。该地区人口的快速增长、医疗投资的增加以及对生物技术研究的日益关注正在推动集群规则间隔短回文重复技术的采用。该地区正在成为农业、医学和生物技术创新应用的温床，重点是基因组学和精准医学。此外，包括中国和印度在内的亚太地区多个国家正在大力投资与集群规则空间短回文重复相关的研发，以促进该技术的扩展和商业化。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球集群规则间隔短回文重复技术市场：依产品

  • 介绍
  • 簇状规则间隙短回文重复试剂盒和酶
  • 设计工具
  • 质粒和载体
  • 引导RNA (gRNA) 设计
  • 细胞株工程
  • 其他产品

第6章全球集群规则间隔短回文重复技术市场：按应用

  • 介绍
  • 药物研发发现与开发
  • 农业
  • 生物燃料
  • 其他用途

第7章全球集群规则间隔短回文重复技术市场：依最终用户分类

  • 介绍
  • 製药和生物技术公司
  • 学术研究所
  • 受託研究机构（CRO）
  • 其他最终用户

第8章全球集群规则间隔短回文重复技术市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第9章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第10章公司简介

  • Agilent Technologies, INC.
  • Applied Stemcell
  • Beam Therapeutics, INC.
  • Caribou Biosciences
  • Cellecta, INC.
  • 簇状规则间隔短回文重复 Therapeutics AG
  • Danaher Corporation
  • Editas Medicine
  • Genecopoeia, INC.
  • Genscript
  • Intellia Therapeutics INC.
  • Lonza Group Ltd.
  • Mammoth Biosciences INC.
  • Merck KGAA
  • Origene Technologies, INC.
  • Synthego Corporation
  • Thermo Fisher Scientific INC.
  • Toolgen INC.
  • Twist bioscience corp.
Product Code: SMRC24255

According to Stratistics MRC, the Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market is accounted for $3.6 billion in 2023 and is expected to reach $11.3 billion by 2030 growing at a CAGR of 17.6% during the forecast period. The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology is the commercial ecosystem surrounding the utilization of CRISPR-based genome editing and gene manipulation techniques. CRISPR technology is used to precisely modify DNA sequences in various organisms, including humans, for purposes such as gene therapy, drug development, and agricultural advancements. Its advantages include its high precision, affordability, and efficiency, making it a revolutionary tool for gene editing with immense potential in healthcare, biotechnology, and scientific research.

According to a study conducted by McMaster University in 2019, over 1.12 million men had haemophilia, and of these 0.4 million had severe haemophilia.

Market Dynamics:

Driver:

Increasing number of ongoing clinical trials

These trials reflect the growing interest and investment in applying CRISPR technology to develop novel therapies for genetic disorders, cancer, and a range of other diseases. As more trials progress, they validate the safety and efficacy of CRISPR-based treatments, driving confidence among regulators, investors, and healthcare providers. This not only paves the way for potential market approvals but also expands the applications of CRISPR, making it a transformative force in the healthcare sector. The abundance of clinical trials signifies the technology's potential to revolutionize medical treatment and underscores its future market growth.

Restraint:

High costs of CRISPR

The initial investment in research, equipment, and specialized expertise required for CRISPR applications can be prohibitively expensive. Additionally, the need for stringent quality control, rigorous testing, and regulatory compliance adds to the overall cost. High licensing fees for CRISPR-related intellectual property can further burden companies and institutions. These elevated expenses can limit the accessibility of CRISPR technology, especially for smaller research entities and organizations with limited budgets, potentially impeding the pace of innovation and adoption.

Opportunity:

Growing government and private investments and funding for CRISPR technology

Increased financial support from both public and private sectors fosters research, development, and commercialization of CRISPR applications. This funding accelerates innovation, expands the range of applications, and enhances the technology's accessibility. It also stimulates collaboration between academic institutions, biotech companies, and pharmaceutical firms, leading to breakthroughs in areas like gene therapy, agriculture, and drug discovery. Moreover, robust financial backing promotes regulatory compliance and ethical considerations, ensuring the responsible and safe use of CRISPR technology, which is crucial for its long-term success and societal acceptance.

Threat:

Regulatory hurdles for CRISPR advancements

The evolving regulatory landscape, characterized by ethical, safety, and intellectual property concerns, can significantly slow down the development and commercialization of CRISPR applications. Stringent regulations and varying guidelines across different countries may create challenges for researchers and companies seeking to bring CRISPR-based products to market. Ethical debates surrounding gene editing in humans and potential ecological impacts in agriculture further complicate the regulatory environment. Intellectual property disputes and licensing complexities can also hinder innovation and market entry. These barriers may limit the speed and scope of CRISPR technology adoption, delaying its potential to address critical healthcare needs, revolutionize agriculture, and advance scientific research.

COVID-19 Impact:

The COVID-19 pandemic has had a mixed impact on the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market. While it temporarily disrupted supply chains and laboratory research, it also highlighted the importance of rapid, precise genome editing techniques. CRISPR technology's potential for diagnostic test development and vaccine research was prominently showcased. Moreover, the pandemic accelerated the adoption of digital collaboration tools and remote access to CRISPR-related research, making it easier for scientists to continue their work. As a result, CRISPR technology has gained greater attention and funding for applications beyond the pandemic, potentially expediting its growth and diversification in research, healthcare, and biotechnology.

The CRISPR kits & enzymes segment is expected to be the largest during the forecast period

The CRISPR kits & enzymes segment is expected to have a lucrative growth. These essential tools provide researchers with the necessary components for precise genome editing. CRISPR kits typically contain guide RNAs, Cas9 proteins, and other reagents needed for target DNA modification. Enzymes, like Cas9, are responsible for cleaving DNA at specific sites. Their ready availability simplifies the CRISPR workflow, enabling more efficient and accurate genetic manipulations for a wide range of applications, from gene therapy and drug discovery to agricultural advancements. The convenience and accessibility of these kits and enzymes drive the widespread adoption and continued growth of CRISPR technology in various scientific and industrial sectors.

The agriculture segment is expected to have the highest CAGR during the forecast period

The agriculture segment is anticipated to witness the fastest CAGR growth during the forecast period. CRISPR technology is revolutionizing the agricultural industry by offering precise and efficient genome editing tools for crop improvement and livestock breeding. It allows for the development of genetically modified crops with enhanced resistance to pests, diseases, and adverse environmental conditions, as well as improved nutritional content. This innovation has the potential to increase crop yields, reduce the need for chemical pesticides, and address food security challenges. CRISPR's applications in agriculture hold great promise for sustainable and more resilient food production, offering a crucial solution to global challenges in the face of a growing population and changing climate.

Region with largest share:

During the forecast period, it is expected that the North American market will continue to hold a majority of the market share. It boasts a robust ecosystem for CRISPR research and applications, characterized by a concentration of leading biotech companies, academic institutions, and research centers. The region's advanced infrastructure, significant investment in life sciences, and supportive regulatory environment have fostered rapid innovation in CRISPR technology. North America has been at the forefront of clinical trials, gene therapy advancements, and the development of CRISPR-based therapies, making it a hub for biotechnological breakthroughs. The strong presence of private and public funding, along with a skilled talent pool, positions North America as a leader in driving the growth and diversification of the CRISPR market.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period. The region's rapidly growing population, rising healthcare investments, and increasing focus on biotechnology research have fuelled the adoption of CRISPR technology. It is becoming a hotbed for innovative applications across agriculture, healthcare, and biotechnology, with a strong emphasis on genomics and precision medicine. Furthermore, several countries in Asia Pacific, including China and India, are making substantial investments in CRISPR-related research and development, driving the technology's expansion and commercialization.

Key players in the market

Some of the key players in Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology market include: Agilent Technologies, INC., Applied Stemcell, Beam Therapeutics, INC., Caribou Biosciences, Cellecta, INC., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Genecopoeia, INC., Genscript, Intellia Therapeutics INC., Lonza Group Ltd., Mammoth Biosciences INC., Merck KGAA, Origene Technologies, INC., Synthego Corporation, Thermo Fisher Scientific INC., Toolgen INC. and Twist bioscience corp.

Key Developments:

In May 2023, Thermo Fisher Scientific opens cell therapy facility at UCSF to accelerate development of breakthrough therapies. Thermo Fisher Scientific Inc. and the University of California, San Francisco accelerated advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center's Mission Bay campus.

In April 2022, Thermo Fisher Scientific Inc. launched the new GMP-manufactured Gibco CTS TrueCut Cas9 Protein to support genome editing for research and manufacturing applications, including CAR T-cell therapy research.

In September 2022, GenScript announced today that it has launched the GenWand Double-Stranded DNA (dsDNA) Service for the manufacture of CRISPR knock-in homology- directed repair (HDR) templates in T cell engineering.

Products Covered:

  • CRISPR kits & Enzymes
  • Design Tools
  • Plasmid & Vector
  • Guide RNA (gRNA) Design
  • Cell Line Engineering
  • Other Products

Applications Covered:

  • Drug Discovery & Development
  • Agriculture
  • Biofuels
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market, By Product

  • 5.1 Introduction
  • 5.2 CRISPR kits & Enzymes
  • 5.3 Design Tools
  • 5.4 Plasmid & Vector
  • 5.5 Guide RNA (gRNA) Design
  • 5.6 Cell Line Engineering
  • 5.7 Other Products

6 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market, By Application

  • 6.1 Introduction
  • 6.2 Drug Discovery & Development
  • 6.3 Agriculture
  • 6.4 Biofuels
  • 6.5 Other Applications

7 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market, By End User

  • 7.1 Introduction
  • 7.2 Pharmaceutical & Biotechnology Companies
  • 7.3 Academic & Research Institutes
  • 7.4 Contract Research Organizations (CROs)
  • 7.5 Other End Users

8 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Agilent Technologies, INC.
  • 10.2 Applied Stemcell
  • 10.3 Beam Therapeutics, INC.
  • 10.4 Caribou Biosciences
  • 10.5 Cellecta, INC.
  • 10.6 CRISPR Therapeutics AG
  • 10.7 Danaher Corporation
  • 10.8 Editas Medicine
  • 10.9 Genecopoeia, INC.
  • 10.10 Genscript
  • 10.11 Intellia Therapeutics INC.
  • 10.12 Lonza Group Ltd.
  • 10.13 Mammoth Biosciences INC.
  • 10.14 Merck KGAA
  • 10.15 Origene Technologies, INC.
  • 10.16 Synthego Corporation
  • 10.17 Thermo Fisher Scientific INC.
  • 10.18 Toolgen INC.
  • 10.19 Twist bioscience corp.

List of Tables

  • Table 1 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By CRISPR kits & Enzymes (2021-2030) ($MN)
  • Table 4 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Design Tools (2021-2030) ($MN)
  • Table 5 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Plasmid & Vector (2021-2030) ($MN)
  • Table 6 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Guide RNA (gRNA) Design (2021-2030) ($MN)
  • Table 7 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 8 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Application (2021-2030) ($MN)
  • Table 10 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 11 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 12 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Biofuels (2021-2030) ($MN)
  • Table 13 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 14 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By End User (2021-2030) ($MN)
  • Table 15 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 16 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 17 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 18 Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 19 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Country (2021-2030) ($MN)
  • Table 20 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Product (2021-2030) ($MN)
  • Table 21 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By CRISPR kits & Enzymes (2021-2030) ($MN)
  • Table 22 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Design Tools (2021-2030) ($MN)
  • Table 23 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Plasmid & Vector (2021-2030) ($MN)
  • Table 24 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Guide RNA (gRNA) Design (2021-2030) ($MN)
  • Table 25 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 26 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 27 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Application (2021-2030) ($MN)
  • Table 28 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 29 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 30 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Biofuels (2021-2030) ($MN)
  • Table 31 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 32 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By End User (2021-2030) ($MN)
  • Table 33 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 34 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 35 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 36 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 37 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Country (2021-2030) ($MN)
  • Table 38 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Product (2021-2030) ($MN)
  • Table 39 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By CRISPR kits & Enzymes (2021-2030) ($MN)
  • Table 40 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Design Tools (2021-2030) ($MN)
  • Table 41 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Plasmid & Vector (2021-2030) ($MN)
  • Table 42 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Guide RNA (gRNA) Design (2021-2030) ($MN)
  • Table 43 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 44 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 45 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Application (2021-2030) ($MN)
  • Table 46 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 47 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 48 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Biofuels (2021-2030) ($MN)
  • Table 49 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 50 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By End User (2021-2030) ($MN)
  • Table 51 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 52 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 53 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 54 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 55 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Country (2021-2030) ($MN)
  • Table 56 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Product (2021-2030) ($MN)
  • Table 57 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By CRISPR kits & Enzymes (2021-2030) ($MN)
  • Table 58 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Design Tools (2021-2030) ($MN)
  • Table 59 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Plasmid & Vector (2021-2030) ($MN)
  • Table 60 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Guide RNA (gRNA) Design (2021-2030) ($MN)
  • Table 61 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 62 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 63 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Application (2021-2030) ($MN)
  • Table 64 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 65 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 66 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Biofuels (2021-2030) ($MN)
  • Table 67 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 68 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By End User (2021-2030) ($MN)
  • Table 69 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 70 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 71 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 72 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Product (2021-2030) ($MN)
  • Table 75 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By CRISPR kits & Enzymes (2021-2030) ($MN)
  • Table 76 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Design Tools (2021-2030) ($MN)
  • Table 77 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Plasmid & Vector (2021-2030) ($MN)
  • Table 78 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Guide RNA (gRNA) Design (2021-2030) ($MN)
  • Table 79 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 80 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 81 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Application (2021-2030) ($MN)
  • Table 82 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 83 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 84 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Biofuels (2021-2030) ($MN)
  • Table 85 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 86 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By End User (2021-2030) ($MN)
  • Table 87 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 88 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 89 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 90 South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 91 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Country (2021-2030) ($MN)
  • Table 92 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Product (2021-2030) ($MN)
  • Table 93 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By CRISPR kits & Enzymes (2021-2030) ($MN)
  • Table 94 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Design Tools (2021-2030) ($MN)
  • Table 95 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Plasmid & Vector (2021-2030) ($MN)
  • Table 96 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Guide RNA (gRNA) Design (2021-2030) ($MN)
  • Table 97 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 98 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 99 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Application (2021-2030) ($MN)
  • Table 100 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 101 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Agriculture (2021-2030) ($MN)
  • Table 102 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Biofuels (2021-2030) ($MN)
  • Table 103 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 104 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By End User (2021-2030) ($MN)
  • Table 105 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 106 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 107 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 108 Middle East & Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Technology Market Outlook, By Other End Users (2021-2030) ($MN)